Crossmark

Glia dysfunction in schizophrenia: evidence of possible therapeutic effects of nervonic acid in a preclinical model

Published Online: 2024-10-21

Published Print: 2024-11

Authors

Wang, Xiaona

Fu, Jiacheng

Wang, Huiying

Liu, Cong

Zhang, Yongping

Song, Cai

Wang, Changhong
Funding

Funding for this research was provided by:

Natural Science Foundation of Guangdong Province (2021A1515011579)

Science and Technology Planning Project of Shenzhen Municipality (GJHZ20190823111414825)
License Information

Text and Data Mining valid from 2024-10-21

Version of Record valid from 2024-10-21
More Information

Article History

Received: 18 July 2023

Accepted: 3 June 2024

First Online: 21 October 2024

Declarations

:

: Human sample collections were reviewed and approved by the Academic and Ethic Committee of the Second Affiliated Hospital of Xinxiang Medical College (XMPB-0022). All animal procedures were approved by the Animal Ethics Committee of Henan Provincial Psychiatric Hospital (HMH. No20210406AEC006), Xinxiang, China.

: No applicable.

: All authors declare that they have no conflict of interest.

Document is current